annual accounts payable:
$4.02B+$222.73M(+5.86%)Summary
- As of today (May 31, 2025), NVO annual accounts payable is $4.02 billion, with the most recent change of +$222.73 million (+5.86%) on December 31, 2024.
- During the last 3 years, NVO annual accounts payable has risen by +$2.67 billion (+198.04%).
- NVO annual accounts payable is now at all-time high.
Performance
NVO Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$2.84B-$1.18B(-29.44%)Summary
- As of today (May 31, 2025), NVO quarterly accounts payable is $2.84 billion, with the most recent change of -$1.18 billion (-29.44%) on March 31, 2025.
- Over the past year, NVO quarterly accounts payable has increased by +$958.25 million (+50.93%).
- NVO quarterly accounts payable is now -33.53% below its all-time high of $4.27 billion, reached on June 30, 2024.
Performance
NVO quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
NVO Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.9% | +50.9% |
| 3 y3 years | +198.0% | +183.3% |
| 5 y5 years | +322.2% | +259.8% |
NVO Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +198.0% | -33.5% | +183.3% |
| 5 y | 5-year | at high | +325.9% | -33.5% | +259.8% |
| alltime | all time | at high | +4619.9% | -33.5% | +3230.3% |
NVO Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $2.84B(-29.4%) |
| Dec 2024 | $4.02B(+5.9%) | $4.02B(+11.6%) |
| Sep 2024 | - | $3.61B(-15.6%) |
| Jun 2024 | - | $4.27B(+127.1%) |
| Mar 2024 | - | $1.88B(-50.5%) |
| Dec 2023 | $3.80B(+69.5%) | $3.80B(+33.5%) |
| Sep 2023 | - | $2.85B(+9.7%) |
| Jun 2023 | - | $2.60B(+76.4%) |
| Mar 2023 | - | $1.47B(-34.4%) |
| Dec 2022 | $2.24B(+66.1%) | $2.24B(+104.3%) |
| Sep 2022 | - | $1.10B(-46.6%) |
| Jun 2022 | - | $2.06B(+105.3%) |
| Mar 2022 | - | $1.00B(-25.8%) |
| Dec 2021 | $1.35B(+42.9%) | $1.35B(-2.5%) |
| Sep 2021 | - | $1.38B(+13.6%) |
| Jun 2021 | - | $1.22B(+13.7%) |
| Mar 2021 | - | $1.07B(+13.4%) |
| Dec 2020 | $944.93M(-0.9%) | $944.93M(-2.1%) |
| Sep 2020 | - | $965.44M(-28.6%) |
| Jun 2020 | - | $1.35B(+71.3%) |
| Mar 2020 | - | $789.23M(-17.2%) |
| Dec 2019 | $953.20M(-7.9%) | $953.20M(+10.4%) |
| Sep 2019 | - | $863.71M(+7.6%) |
| Jun 2019 | - | $802.70M(+26.5%) |
| Mar 2019 | - | $634.48M(-38.7%) |
| Dec 2018 | $1.03B(+14.5%) | $1.03B(+37.3%) |
| Sep 2018 | - | $753.99M(-16.6%) |
| Jun 2018 | - | $904.35M(+32.9%) |
| Mar 2018 | - | $680.62M(-24.7%) |
| Dec 2017 | $904.05M(+5.8%) | $904.05M(+26.1%) |
| Sep 2017 | - | $717.01M(+9.5%) |
| Jun 2017 | - | $654.85M(+20.5%) |
| Mar 2017 | - | $543.28M(-36.4%) |
| Dec 2016 | $854.82M(+18.4%) | $854.82M(+27.3%) |
| Sep 2016 | - | $671.53M(-15.8%) |
| Jun 2016 | - | $797.39M(+40.2%) |
| Mar 2016 | - | $568.63M(-21.2%) |
| Dec 2015 | $721.71M(-10.7%) | $721.71M(+24.4%) |
| Sep 2015 | - | $579.98M(-1.9%) |
| Jun 2015 | - | $591.10M(+1.6%) |
| Mar 2015 | - | $581.91M(-28.0%) |
| Dec 2014 | $808.19M(+6.7%) | $808.19M(+58.7%) |
| Sep 2014 | - | $509.33M(-6.8%) |
| Jun 2014 | - | $546.65M(-14.9%) |
| Mar 2014 | - | $642.61M(-15.2%) |
| Dec 2013 | $757.39M(+10.7%) | $757.39M(+42.8%) |
| Sep 2013 | - | $530.31M(+4.6%) |
| Jun 2013 | - | $506.89M(-4.2%) |
| Mar 2013 | - | $529.19M(-22.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $683.97M(+19.3%) | $683.97M(+46.9%) |
| Sep 2012 | - | $465.60M(+5.3%) |
| Jun 2012 | - | $442.17M(-3.5%) |
| Mar 2012 | - | $458.11M(-20.1%) |
| Dec 2011 | $573.49M(+10.6%) | $573.49M(+36.6%) |
| Sep 2011 | - | $419.77M(-18.7%) |
| Jun 2011 | - | $516.59M(-3.3%) |
| Mar 2011 | - | $534.18M(+3.0%) |
| Dec 2010 | $518.40M(+20.2%) | $518.40M(+41.4%) |
| Sep 2010 | - | $366.51M(-5.2%) |
| Jun 2010 | - | $386.57M(+8.8%) |
| Mar 2010 | - | $355.36M(-17.6%) |
| Dec 2009 | $431.23M(+0.6%) | $431.23M(+42.6%) |
| Sep 2009 | - | $302.40M(-3.3%) |
| Jun 2009 | - | $312.88M(+0.9%) |
| Mar 2009 | - | $310.03M(-27.7%) |
| Dec 2008 | $428.64M(+12.5%) | $428.64M(+49.3%) |
| Sep 2008 | - | $287.07M(-15.6%) |
| Jun 2008 | - | $340.19M(+2.7%) |
| Mar 2008 | - | $331.09M(-13.1%) |
| Dec 2007 | $381.04M(+25.8%) | $381.04M(+31.9%) |
| Sep 2007 | - | $288.84M(-0.4%) |
| Jun 2007 | - | $290.00M(+7.4%) |
| Mar 2007 | - | $270.00M(-10.8%) |
| Dec 2006 | $302.82M(+27.2%) | $302.82M(+54.5%) |
| Sep 2006 | - | $196.00M(-7.9%) |
| Jun 2006 | - | $212.82M(-6.6%) |
| Mar 2006 | - | $227.75M(-4.3%) |
| Dec 2005 | $238.00M(+22.2%) | $238.00M(+48.8%) |
| Sep 2005 | - | $159.91M(-17.0%) |
| Jun 2005 | - | $192.72M(+8.2%) |
| Mar 2005 | - | $178.10M(-8.6%) |
| Dec 2004 | $194.81M(+13.9%) | $194.81M(+58.3%) |
| Sep 2004 | - | $123.03M(-7.4%) |
| Jun 2004 | - | $132.85M(+15.6%) |
| Mar 2004 | - | $114.92M(-32.8%) |
| Dec 2003 | $171.01M(+40.3%) | $171.01M(+40.3%) |
| Dec 2002 | $121.89M(+6.1%) | $121.89M(+6.1%) |
| Dec 2001 | $114.84M(-5.9%) | $114.84M(-5.9%) |
| Dec 2000 | $122.01M(+12.2%) | $122.01M(+12.2%) |
| Dec 1999 | $108.76M(-9.9%) | $108.76M(-9.9%) |
| Dec 1998 | $120.71M(+41.6%) | $120.71M(+41.6%) |
| Dec 1997 | $85.27M(-35.2%) | $85.27M(-35.2%) |
| Dec 1996 | $131.50M(-73.2%) | $131.50M(-73.2%) |
| Dec 1995 | $490.40M(+189.8%) | $490.40M(+189.8%) |
| Dec 1994 | $169.24M(+23.6%) | $169.24M(+23.6%) |
| Dec 1993 | $136.90M(-60.2%) | $136.90M(-60.2%) |
| Dec 1992 | $344.33M(+175.2%) | $344.33M(+175.2%) |
| Dec 1991 | $125.10M(+10.7%) | $125.10M(+10.7%) |
| Dec 1990 | $112.98M | $112.98M |
FAQ
- What is Novo Nordisk A/S annual accounts payable?
- What is the all time high annual accounts payable for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual accounts payable year-on-year change?
- What is Novo Nordisk A/S quarterly accounts payable?
- What is the all time high quarterly accounts payable for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly accounts payable year-on-year change?
What is Novo Nordisk A/S annual accounts payable?
The current annual accounts payable of NVO is $4.02B
What is the all time high annual accounts payable for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual accounts payable is $4.02B
What is Novo Nordisk A/S annual accounts payable year-on-year change?
Over the past year, NVO annual accounts payable has changed by +$222.73M (+5.86%)
What is Novo Nordisk A/S quarterly accounts payable?
The current quarterly accounts payable of NVO is $2.84B
What is the all time high quarterly accounts payable for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly accounts payable is $4.27B
What is Novo Nordisk A/S quarterly accounts payable year-on-year change?
Over the past year, NVO quarterly accounts payable has changed by +$958.25M (+50.93%)